Mark J. Midwinter

Prof. Mark J. Midwinter

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in The Lancet
Verified
Journal Article
Closed access
JLJanet Lord
Janet Lord
MMMark J. Midwinter
Mark J. Midwinter
YCYen-Fu Chen
Yen-Fu Chen
ABAntonio Belli
Antonio Belli
KBKarim Brohi
Karim Brohi
RLRichard J Lilford
Richard J Lilford

1 February 2012 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
JMJonathan Morrison
Jonathan Morrison
TRTodd E. Rasmussen
Todd E. Rasmussen
MMMark J. Midwinter
Mark J. Midwinter
Vascular disruption with concomitant hemorrhage is a leading cause of death in civilian and military trauma.1,2 Experience from the wars in Iraq and Afghanistan has led to advances in resuscitation for hemorrhagic shock, with identification of optimum ratios of blood components to be used in this setting.3-5 These new strategies are based on early and balanced administration of packed red blood cells (PRBCs), fresh frozen plasma (FFP), platelets, and cryoprecipitate to restore circulating volume and clotting factors.6 Despite these advances, the effectiveness of a medication to improve mortality in the setting of hemorrhagic shock has not been established.

1 February 1999 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
MMMark J. Midwinter
Mark J. Midwinter
CBC. J. Beveridge
C. J. Beveridge
JWJ. B. Wilsdon
J. B. Wilsdon
MBM. K. Bennett
M. K. Bennett
CBC. J. Baudouin
C. J. Baudouin
RCR. M. Charnley
R. M. Charnley
Background: Spiral computed tomography (CT) allows high-resolution examination of the pancreas, surrounding vascular structures, lymph nodes and liver. Endoscopic ultrasonography (EUS) also allows high-resolution imaging of the pancreas and adjacent structures but is an invasive procedure. With the availability of spiral CT, the role of EUS in the investigation of patients with suspected pancreatic or ampullary tumours is unclear. Methods: Forty-eight patients with clinical suspicion of a pancreatic or ampullary tumour underwent both spiral CT and EUS. Thirty-four patients had surgical exploration, of whom 17 underwent pancreatic resection and 17 had biliary and gastric bypass. The results of spiral CT and EUS were compared with the operative findings. Results: The final histological diagnosis was ductal adenocarcinoma (24 patients), ampullary carcinoma (six), serous cystadenoma (two) and chronic pancreatitis (two). EUS demonstrated 33 and spiral CT 26 of the 34 primary lesions. EUS was particularly useful in the assessment of small resectable tumours missed by spiral CT. The sensitivity and specificity of EUS and spiral CT for detecting involvement by the tumour of the superior mesenteric vein, portal vein and lymph nodes were similar, but EUS was less effective at evaluating the superior mesenteric artery. Conclusion: EUS is an important additional investigation after spiral CT in patients with a suspected pancreatic or ampullary tumour.

1 March 2013 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
JMJonathan Morrison
Jonathan Morrison
JRJames D. Ross
James D. Ross
JDJoseph J. Dubose
Joseph J. Dubose
JJJan O. Jansen
Jan O. Jansen
MMMark J. Midwinter
Mark J. Midwinter
TRTodd E. Rasmussen
Todd E. Rasmussen
Hemorrhage resultant from vascular disruption remains the predominant cause of preventable battlefield mortality1,2 and the leading cause of preventable death in civilian trauma.3-5 Acute traumatic coagulopathy is associated with a 4-fold increase in mortality and is characterized by both anticoagulation and fibrinolysis.6 Fibrinolysis is a key protective or regulatory mechanism that prevents the extension of formed clot beyond the site of injury7 but may become pathologic following injury and shock.8 When present in the setting of trauma, excessive fibrinolysis (ie, hyperfibrinolysis) is associated with a mortality rate of 48% to 100%.9-12

1 May 2011 in Injury
Verified
Journal Article
Closed access
JGJ. Granville-Chapman
J. Granville-Chapman
NJN. Jacobs
N. Jacobs
MMMark J. Midwinter
Mark J. Midwinter

1 May 2015 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Open access
JPJowan G. MB ChB Penn-Barwell
Jowan G. MB ChB Penn-Barwell
SRStuart A.G. MB ChB Roberts
Stuart A.G. MB ChB Roberts
MMMark J. Midwinter
Mark J. Midwinter
JBJon R.B. Bishop
Jon R.B. Bishop
BACKGROUND The United Kingdom was at war in Iraq and Afghanistan for more than a decade. Despite assertions regarding advances in military trauma care during these wars, thus far, no studies have examined survival in UK troops during this sustained period of combat. The aims of this study were to examine temporal changes of injury patterns defined by body region and survival in a population of UK Military casualties between 2003 and 2012 in Iraq and Afghanistan. METHODS The UK Military Joint Theatre Trauma Registry was searched for all UK Military casualties (survivors and fatalities) sustained on operations between January 1, 2003, and December 31, 2012. The New Injury Severity Score (NISS) was used to stratify injury severity. RESULTS There were 2,792 UK Military casualties sustaining 14,252 separate injuries during the study period. There were 608 fatalities (22% of all casualties). Approximately 70% of casualties injured in hostile action resulted from explosive munitions. The extremities were the most commonly injured body region, involved in 43% of all injuries. The NISS associated with a 50% chance of survival rose each year from 32 in 2003 to 60 in 2012. CONCLUSION An improvement in survival during the 10-year period is demonstrated. A majority of wounds are a result of explosive munitions, and the extremities are the most commonly affected body region. The authors recommend the development of more sophisticated techniques for the measuring of the performance of combat casualty care systems to include measures of morbidity and functional recovery as well as survival. LEVEL OF EVIDENCE Epidemiologic study, level III.